Skip to main content
Top

Journal of Thrombosis and Thrombolysis

Issue 2/2010

Content (19 Articles)

Warfarin after anterior myocardial infarction in current era of dual antiplatelet therapy: a randomized feasibility trial

Jon-David R. Schwalm, Mayraj Ahmad, Omid Salehian, John W. Eikelboom, Madhu K. Natarajan

Impact of diabetes on long-term outcome in STEMI patients undergoing primary angioplasty with glycoprotein IIb–IIIa inhibitors and BMS or DES

Giuseppe De Luca, Rosario Sauro, Attilio Varricchio, Michele Capasso, Tonino Lanzillo, Fiore Manganelli, Ciro Mariello, Francesco Siano, Giannignazio Carbone, Maria Rosaria Pagliuca, Giuseppe Rosato, Emilio Di Lorenzo

Heparin–platelet factor 4 antibodies in intensive care patients: an observational seroprevalence study

Robert L. Levine, Georgene W. Hergenroeder, John L. Francis, Charles C. Miller, Marcie J. Hursting

The effect of low molecular weight heparin (dalteparin) on duration and initiation of labour

Nazim Isma, Peter J. Svensson, Bengt Lindblad, Pelle G. Lindqvist

Human cytomegalovirus increases HUVEC sensitivity to thrombin and modulates expression of thrombin receptors

Milan Popović, Svetlana Paskaš, Maja Živković, Ladislav Burysek, Yves Laumonnier

Mesenteric vein thrombosis after laproscopic gastric sleeve procedure

Kaushang Gandhi, Parminder Singh, Mala Sharma, Harit Desai, John Nelson, Ashoutosh Kaul

Gender differences in platelet aggregation in healthy individuals

Mohammad Otahbachi, Jan Simoni, Grace Simoni, John F. Moeller, Cihan Cevik, Gary E. Meyerrose, Chanwit Roongsritong

Abnormal Protac-induced coagulation inhibition chromogenic assay results are associated with an increased risk of recurrent venous thromboembolism

Armando Tripodi, Cristina Legnani, Laura Lemma, Benilde Cosmi, Gualtiero Palareti, Veena Chantarangkul, Pier Mannuccio Mannucci

Accuracy assessment of pharmacogenetically predictive warfarin dosing algorithms in patients of an academic medical center anticoagulation clinic

Paul B. Shaw, Jennifer L. Donovan, Maichi T. Tran, Stephenie C. Lemon, Pamela Burgwinkle, Joel Gore

Budd-Chiari syndrome, mediastinal mass and recalcitrant leg ulcers, an unlikely trio

Alfonso Tafur, Waldemar Wysokinski, Terri Vrtiska, Robert McBane II

Recurrent ischemic stroke in a patient with idiopathic thrombocytopenic purpura

Hak Young Rhee, Hye-Yeon Choi, Sang-Beom Kim, Won-Chul Shin

Magnetic resonance venography and genetics of a female patient with pelvic venous thrombosis

Thomas G. Perkins, Rahul K. Mishra, Yasmin Siddiqui, Eric H. Hanson, Robb K. Rowley, Erica R. Ramos, William W. Orrison Jr.

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine